INTRODUCTION
============

Intestinal ischemia reperfusion (IR), or transient hypoxia followed by re-oxygenation, is a component of the pathogenesis of all diseases that involve a reduction or redistribution of bowel blood flow, including shock, neonatal necrotizing enterocolitis, intestinal transplant, and mesenteric ischemia. As such, IR can complicate surgical procedures in the elderly and for open-heart surgery patients ([@b1-cln_68p1034]--[@b3-cln_68p1034]). In clinical practice, symptoms are often vague, making a definitive diagnosis of acute intestinal ischemia notoriously difficult ([@b4-cln_68p1034]). When accompanied by clinical signs of peritonitis, this usually indicates necrosis of the intestinal wall, and the suspicion of intestinal ischemia is traditionally confirmed by laparotomy ([@b5-cln_68p1034]).

In humans, the systematic search for serological markers of intestinal ischemia to optimize early diagnosis has identified molecules such as D-lactate ([@b6-cln_68p1034]), glutathione S-transferase (GST) ([@b7-cln_68p1034]), and intestinal fatty acid binding protein (iFABP) ([@b8-cln_68p1034],[@b9-cln_68p1034]). However, a combination of markers, or a "diagnostic intestinal ischemia panel," reflecting different aspects of bowel viability has not been identified ([@b10-cln_68p1034]). The temporal association between IR and serum markers is also not well understood. The identification of a set of serum markers (SM) that could detect or predict the outcome of an ischemic insult would be essential for studying the pathophysiology of IR.

Numerous publications have reported the effects of drugs and therapeutic modalities on IR injury based on histological damage ([@b11-cln_68p1034],[@b12-cln_68p1034]) and alterations of serum levels of molecules that are associated with cell damage, endothelial activation, inflammation, and oxidative stress ([@b13-cln_68p1034]--[@b15-cln_68p1034]). However, the evaluation times are often fixed or arbitrary, and the temporal dynamics of histological and serological injury markers remain obscure. Nonetheless, in most studies of experimental IR, histopathological examination is the gold standard. In 1970, Chiu reported a graded scale of damage produced by ischemia in the intestinal mucosa based on hematoxylin and eosin staining ([@b12-cln_68p1034]). Later, Parks and Sonnino reported scores, and Park reported a modification to the original Chiu score ([@b16-cln_68p1034]). The Chiu and Chiu/Parks classifications are currently recommended for comparing results reported in the literature ([@b11-cln_68p1034],[@b17-cln_68p1034]).

In this article, we were interested in identifying combinations of serum and histopathological studies at different time points. Therefore, we assessed the evolution of histopathological injury and serum markers of non-specific cell damage: aspartate aminotransferase (AST), alanine aminotransaminase (ALT), and lactic dehydrogenase (LDH), of acute inflammation: tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and interleukin-1 beta (IL-1), and of intestinal mucosa damage: intestinal fatty acid binding protein (iFABP) and D-lactate during reperfusion.

MATERIAL AND METHODS
====================

Animals procedures
------------------

The animal procedures were performed in accordance with the proper use and care of laboratory animals. The experiments were performed on 35 female Wistar rats weighing 200--250 g. The animals were maintained under standard conditions, including stable room temperature, a 12:12-h light/dark cycle, and access to commercial rat pellets and water *ad libitum*. The ethics committee of our institution approved this study.

Animal model
------------

In brief, after 12 hours of fasting and anesthesia with a 40 mg/kg intraperitoneal injection (IP) of pentobarbital sodium (Anestesal; Pfizer, Mexico City, Mexico), a midline laparotomy was performed, and ischemia was induced by occlusion of the superior mesenteric artery with vascular clamps. An absent pulse was visually verified in the mesenteric vessels with a brown discoloration of the intestine. After 30 minutes of ischemia, blood flow was restored, and the abdominal wall was sutured.

The animals were divided into 7 groups (n = 5) and were named according to the reperfusion time: Sham group or negative control, which underwent surgery without arterial occlusion, and groups with 1 hour, 3 hours, 6 hours, 12 hours, 24 hours, and 48 hours of reperfusion.

Depending on the group, at the end of the reperfusion time, the rats were anesthetized, the sutures were removed, blood samples were obtained from the aorta, and full-bowel wall samples of the ileum, 15 cm from the ileocecal junction, were obtained. The animals were then euthanized by exsanguination.

Morphological examination
-------------------------

Intestinal biopsies were fixed in 10% formalin, processed with conventional histological techniques, and stained with hematoxylin and eosin. To assess mucosal injury, the Chiu classification was used ([@b6-cln_68p1034]). The evaluation scale was from 0 to 5, where 0 is a normal intestinal mucosa, 1 is the development of Gruenhagen subepithelial spaces, 2 is the extension of the subepithelial space with moderate lifting of the lamina propria, 3 is the expansion of epithelial lifting with destruction of the tips of villi, 4 is destroyed villi with exposure of the lamina propria and dilated capillaries, and 5 is the disintegration of the lamina propria, hemorrhage, and ulceration.

Serum determinations
--------------------

After exsanguinating the animal, at least 3 mL of blood was collected and allowed to clot, and the serum was separated by centrifugation and stored at −70°C until further study.

The serum levels of TNF-alpha were determined using a Rat TNF-alpha enzyme-linked immunosorbent assay (ELISA) kit (Peprotech, Rocky Hill, NJ, USA). Serum levels of IL-1 were determined using a Rat IL-1 beta ELISA kit (Peprotech). Serum levels of IL-6 were determined using a Rat IL-6 ELISA kit (Peprotech). The serum levels of iFABP were determined using a Rat iFABP ELISA kit (Biotang, Waltham, MA, USA). The serum levels of D-lactate were determined using a EnzyChrom™ D-Lactate Assay Kit (BioAssay Sytems, Hayward, CA, USA).

The serum levels of AST, ALT and LDH activity were determined by reflectance on a Vitros DT60II System Ortho Clinical Diagnostics by Johnson & Johnson (Rochester, New York, USA).

Statistical analysis
--------------------

Using SPSS V15 software, we plotted the time variations in the parameters studied, identified the peaks (Pmax) for each parameter and compared them against the baseline (Sham) with t tests for two independent samples. A value of *p*\<0.05 was considered to be statistically significant.

RESULTS
=======

Histopathological changes
-------------------------

The histomorphological damage to the intestinal epithelium according to the Chiu scale was evident in our model at one hour, was maximal at three hours, and returned to baseline levels after 12 hours of reperfusion. The damage was undetectable at 24 and 48 hours ([Figure 1](#f1-cln_68p1034){ref-type="fig"}).

Non-specific markers of cell damage
-----------------------------------

Of the non-specific markers of cell damage, LDH peaked at one hour of reperfusion, AST peaked at 6 hours and ALT peaked at 12 hours. The latter two showed a significant elevation at 3 hours ([Figure 1](#f1-cln_68p1034){ref-type="fig"}).

TNF-alpha, IL-1beta, IL-6, iFABP and D-lactate
----------------------------------------------

The markers whose levels coincided with the peak of injury (Pmax) were TNF-alpha and IL-1beta, which peaked at one hour and remained elevated until 3 hours. No differences were observed at 6 hours compared to the control group. Serum D-lactate did not decrease after reaching its maximum at 3 hours ([Figure 1](#f1-cln_68p1034){ref-type="fig"}). The levels of IL-6 peaked at 12 hours of reperfusion but did not differ from the controls. The iFABP concentration did not significantly differ from the controls at any time.

Significant differences were documented between the sham group and Pmax in injury scores, non-specific injury markers (LDH, AST and ALT), the inflammatory markers TNF-alpha and IL-1beta, and the specific injury marker D-lactate. There were no significant differences in the concentrations of iFABP or IL-6 ([Table 1](#t1-cln_68p1034){ref-type="table"}).

DISCUSSION
==========

The intestinal mucosa is particularly sensitive to IR injury. We observed severe mucosal injury beginning at 1 hour of perfusion, reaching maximal severity at 3 hours and subsiding at 24 hours. This is consistent with other reports that morphological intestinal repair begins shortly after 3 hours of reperfusion and is complete around 24 hours ([@b18-cln_68p1034]--[@b20-cln_68p1034]). During reperfusion, the cascade of events that seeks to limit damage and maintain homeostasis involves all the components of the digestive tract: mucous cells, fibroblasts, neurons, endothelial cells and the immune system ([@b21-cln_68p1034]). Previous studies have correlated the duration of ischemia with histological damage to the intestinal mucosa ([@b22-cln_68p1034]). At 30 minutes of ischemia, cellular reserves of oxygen are consumed ([@b12-cln_68p1034]), and the mucosa loses its ability to accumulate sugars and amino acids against a concentration gradient ([@b23-cln_68p1034]). Histological lesions secondary to ischemia are exacerbated by reperfusion. The period of time of ischemia, the type of ischemia (arterial, venous, arterial and venous) ([@b24-cln_68p1034]), and the time to reperfusion all determine the severity of injury.

The concentrations of LDH and IL-1 increased before the lesion was identified histopathologically. LDH is a non-specific marker of cell injury and has been associated with ischemic events in the intestine ([@b25-cln_68p1034]), while interleukin-1 beta is considered a marker of acute inflammation, resulting in the activation of macrophages during early stages of tissue injury. Serum levels of LDH, but not IL-1beta, have been shown to remain elevated 72 hours after intestinal IR in rats ([@b26-cln_68p1034]). Peak serum concentrations of D-lactate and TNF-alpha coincided with histopathological injury. TNF-alpha, in concordance with previous reports ([@b24-cln_68p1034]), increased upon injury. Both TNF and IL-1 are essential in the physiopathology of IR and are widely used in studies evaluating intestinal IR injury ([@b27-cln_68p1034]). Additionally, the intestine has been identified as a source of TNF during IR-mediated damage ([@b28-cln_68p1034]). However, these are non-specific markers of inflammation and systemic injury, which makes their diagnostic utility questionable.

Intestinal gut barrier dysfunction is an important aspect of the physiopathology of IR injury. Intestinal bacteria produce D-lactate, and its presence in serum reflects a major failure of the mucosal barrier ([@b25-cln_68p1034]). In a systematic literature review of clinical studies, D-lactate was indeed found to be one of the most well studied and reliable biomarkers of intestinal ischemia ([@b10-cln_68p1034]). However, in a rat model of gut IR induced by aortic clamping, D-lactate was not elevated in the serum after 1 hour of reperfusion following 40 minutes of ischemia, consistent with our results ([@b29-cln_68p1034]). We did find that D-lactate was elevated at 3 hours, which coincided with severe mucosal injury and, presumably, gut barrier dysfunction. This suggests that D-lactate sensitivity is time-dependent and correlates to structural mucosal injury.

Interestingly, D-lactate remained elevated at 48 hours. This could indicate prolonged functional impairment and bacterial translocation independent of mucosal morphological integrity. Support for this idea comes from previous studies that showed elevated D-lactate at 48 hours of reperfusion and correlated to bacteremia following 1 hour of intestinal ischemia in rats ([@b30-cln_68p1034]). Human studies have confirmed persistent elevations of D-lactate 48 hours after reperfusion during colonic ischemia ([@b31-cln_68p1034]). The temporal dynamics of tight-junction alterations in the intestinal mucosa, thought to be a basis for barrier dysfunction after IR ([@b32-cln_68p1034]), could partly explain this result. Additionally, experimental studies in primates have shown that serum D-lactate levels can predict mortality in models of hemorrhagic shock ([@b33-cln_68p1034]). This adds to the possible clinical value of D-lactate as a biomarker in settings of intestinal IR.

Another specific mucosal injury marker, iFABP ([@b25-cln_68p1034]), was unrelated to histopathology during the acute phase in our study. Rat models of acute intestinal IR have shown elevations of iFABP early in the course of intestinal mucosal injury ([@b34-cln_68p1034]). Clinical studies have documented an elevation of iFABP as a specific marker for mucosal injury. Although the source of iFABP is assumed to be the cells of the intestinal mucosa, its utility is based on the identification of a chronic process of local lesions ([@b8-cln_68p1034],[@b9-cln_68p1034],[@b25-cln_68p1034]). However, recent clinical studies have found elevations of iFABP during acute intestinal necrosis ([@b35-cln_68p1034]). Not all studies have been consistent: iFABP was not correlated to intestinal IR at any time point (1, 3 and 6 hours reperfusion) in a recent study in rabbits ([@b36-cln_68p1034]). Together with our results, this suggests that the role of iFABP as a biomarker for intestinal ischemia remains unclear.

We identified ALT and AST as molecules that remained elevated even after histopathological injury had subsided, peaking at 6 and 24 hours post-ischemia. A previous study showed that AST and LDH elevations occurred early after IR, but no ALT elevations were evident at 120 minutes of reperfusion ([@b37-cln_68p1034]). This suggested that the origin of AST and LDH was indeed the intestine and not the liver. In our study, we also found delayed ALT elevations. During reperfusion, peripheral organs, such as the lung and liver, displayed injury as a result of polymorphonuclear leukocyte infiltration and the release of inflammatory mediators into the bloodstream ([@b38-cln_68p1034]). Liver and lung injury indeed occur after intestinal IR, and the elevation of these enzymes appears to reflect remote organ damage ([@b39-cln_68p1034]).

The use of fixed time models of intestinal IR injury using serum markers as surrogates for histopathological analysis should be discouraged. Both serum markers and histology are important in grading the severity of IR injury. Additionally, the chosen markers should ideally coincide with mucosal injury. Studying the changes in concentration of these markers during experimentation will allow for a better understanding of the process. When planning a study on IR injury, it is essential to identify the times at which measurements will be carried out, as this could reflect different aspects of the physiopathology.

Our study has several limitations. We only used one ischemia time (30 minutes), making it impossible to directly establish correlations between the serum markers and local or systemic injury. We used a sublethal model of intestinal IR and could not make associations with mortality. We did not directly measure for mucosal barrier permeability, and we did not carry out immunohistochemical or ultrastructural investigations of the injured mucosa. These are areas of future research.

In conclusion, AST, LDH, IL-1 and TNF-alpha are elevated early after reperfusion, and in the case of TNF-alpha, correlate well with maximal mucosal injury. However, they are non-specific markers of tissue injury (AST, LDH) or part of the systemic inflammatory response (IL-1, TNF-alpha). Their utility as diagnostic tools is thus limited, but they could reflect injury severity. We were surprised not to find changes in IL-6 levels considering the evidence of its involvement in IR injury ([@b26-cln_68p1034]--[@b40-cln_68p1034]). D-lactate is a more promising clinical biomarker of intestinal injury and could be used to evaluate functional (barrier) alterations. It coincided with maximal injury in our study and remained elevated after 48 hours. However, D-lactate was not elevated in the hyperacute phase of intestinal ischemia (1 hour of reperfusion). The specific roles of other markers, such as iFABP, coagulation parameters ([@b41-cln_68p1034]), oxidative stress ([@b42-cln_68p1034]), and adhesion molecules ([@b40-cln_68p1034]), requires further investigation.
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###### 

Serum Markers and Cell Damage Sham group *vs* pMax.

              Sham X±DE        (pMax) X±DE        *p-*value\*\*
  ----------- ---------------- ------------------ ---------------
  Chiu        0.6±0.54         2.40±0.54          0.001
  LDH         1129.00±190.08   10174.00±4558.73   0.01
  AST         204.60±54.66     301.75±72.08       0.05
  ALT         54.50±10.21      110.40±45.9        0.05
  IL-1 beta   0.64±0.52        1.63±0.30          0.009
  IL-6        3.65±1.19        5.30±2.97          **0.28**
  TNF-alpha   1.23±0.23        3.17±1.49          0.04
  iFABP       21.50±5.95       24.10±4.53         **0.46**
  D-lactate   5.25±1.70        8.92±0.86          0.009

Chiu: histopathological damage scored according to Chiu. LDH: lactic dehydrogenase in U/L. AST: aspartate aminotransferase in U/L. ALT: alanine aminotransaminase in U/L. IL-1 beta: interleukin-1 beta in ng/mL, IL-6: interleukin-6 in ng/mL, TNF-alpha: tumor necrosis factor alpha in ng/mL, D-lactate in mM/mcgL, iFABP: intestinal fatty acid binding protein in pg/mL. *P*-value in independent t tests.
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